INSIGHTS ON DRUG DEVELOPMENT
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
VEGF Signaling Pathway
In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.
-
Building A Human-Centric Future For Biologics Development
Biologics are advancing rapidly, but complexity challenges traditional models. Gain insight into how human-relevant approaches like NAMs and microphysiological systems are gaining traction.
-
Are You Keeping Pace With Oligo Synthesis Optimization?
The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.
-
ITC For Binding Characterization In Pharmaceutical Research4/24/2025
Discover an Isothermal Titration Calorimetry tool that is precise for characterizing molecular interactions, which is crucial for drug discovery and lead optimization in pharmaceutical research.
-
Quality Assurance In IVT RNA Vaccine Development Using Electrophoresis2/20/2025
Discover advanced solutions for IVT RNA synthesis, focusing on enhancing fidelity in throughput, innovative technologies, and methodologies to optimize your RNA research and development processes.
-
Complementary Methodologies For Analysis Of NISTmAb Impurities2/27/2026
Gain insight into how SEC and CE‑SDS complement each other to assess monoclonal antibody size variants, offering stronger insight into aggregates, fragments, and overall purity.
-
Your AKTA Oligosynt™ System : It's More Than A Machine2/9/2026
Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.
-
Understanding Biotherapeutic Peptides And GLP-1 Receptor Agonists9/2/2025
Biotherapeutic peptides offer enhanced safety and efficacy over traditional drugs. Learn why rigorous impurity profiling is vital to ensure product quality, patient safety, and regulatory compliance.
DRUG DEVELOPMENT SOLUTIONS
-
Easily analyze a diverse array of RNA species, from 50-9,000 bases, and achieve high-resolution data with a purity & integrity kit.
-
Explore chemical probes that are selective small-molecule modulators of a protein’s function.
-
The iCELLis™ bioreactor system is an automated, single-use, fixed-bed bioreactor that provides excellent cell growth conditions for adherent cells.
-
Routine cell culture? Check!
For researchers who need consistent experimental outcomes, Mateo TL enables all lab members to check and document cell growth status conveniently and comfortably.
Measure confluency consistently, thereby increasing the confidence in the success of their downstream experiments.
-
Our team of analytical experts provides experience, efficiency, and technical proficiency in the development/validation of analytical methodology and GMP testing support for your project.